Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors

Bobin Wu, Yanchun Yang, Xiangyu Qin, Shuzhen Zhang, Chaojun Jing, Changjin Zhu*, Bing Ma

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)

Abstract

ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range.

Original languageEnglish
Pages (from-to)1913-1917
Number of pages5
JournalChemMedChem
Volume8
Issue number12
DOIs
Publication statusPublished - Dec 2013

Keywords

  • aldehyde reductases
  • aldose reductases
  • diabetes complications
  • inhibitors
  • polyol pathway
  • quinoxalines
  • structure-activity relationships

Fingerprint

Dive into the research topics of 'Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors'. Together they form a unique fingerprint.

Cite this